podcast

R&D

Roche on COVID-19 healthcare and testing: the pharmaphorum p...

For episode 30 I spoke with Dr Ashton Harper, who’s head of medical affairs in the UK and Ireland at Roche Diagnostics, about the pressure COVID-19 has put on healthcare systems.

R&D

Richard Francis on his Purespring plans: the pharmaphorum po...

In this episode of the pharmaphorum podcast, our news editor Richard Staines talks to Richard Francis, who took over as CEO of gene therapy company Purespring Therapeutics earlier this mont

Podcasts

AstraZeneca on diversity: the pharmaphorum podcast

The theme for episode 28 of the pharmaphorum podcast is diversity and inclusion in pharma, ably addressed by AstraZeneca’s Rebekah Martin.

R&D

The Alderley Park Discovery Podcast: Life science skills, st...

Episode two of the Alderley Park Discovery Podcast covers access to skills in the life sciences sector, with a focus on support for aspiring scientists and UK staffing trends.

R&D

J&J and medical device innovation: the pharmaphorum podcast

In episode 27 of the pharmaphorum podcast I’m joined by Erin McEachren, who’s EU regional vice president at J&J Surgical Vision.

R&D

Tay-Sachs and rare disease registries – the Health Heroes po...

Episode four of Kantar Health’s Health Heroes podcast tackles pharma’s rare disease challenges, the role of patient registries and hears a moving story about the rare genetic disorder Tay-S